This session provides a focused overview of drug testing in addiction medicine, including available testing modalities and their role in clinical care, aligned with the ACAAM National Addiction Medicine Didactic Curriculum and ABPM content areas.
What This Covers • Available drug testing modalities and appropriate use in clinical settings • Interpretation of urine drug screens, including metabolism of commonly used substances • Common pitfalls in drug testing and factors that influence detection and accuracy • Use of point-of-care and confirmatory testing strategies • Integration of drug test results into clinical decision-making and treatment planning • Case-based application of practical approaches to interpreting results and supporting patient care
How This Resource Is Used This session is designed for on-demand learning and targeted content review. It can be used to reinforce specific knowledge areas or as part of structured board preparation.
Valerie Carrejo, MD, FAAFP FASAM
Dr. Carrejo is the Program Director of the Addiction Medicine Fellowship at the University of New Mexico and a family medicine physician specializing in addiction medicine. She is board certified in Family Medicine and Addiction Medicine.
Her clinical work focuses on the evaluation and treatment of substance use disorders, with an emphasis on integrating addiction care into primary care settings.
To support a meaningful learning experience and recognize your participation:
Access PeriodAccess to this recording is available through June 30, 2027, in alignment with ACAAM’s annual academic cycle.
Recording Release CycleACAAM releases updated recorded sessions each July based on the prior academic year’s didactic series. These recordings are available for a limited time and are retired on June 30 of the following year as new content is released.